<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-157557</identifier>
<setSpec>1889-1837</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Primary hyperaldosteronism due to unilateral adrenal hyperplasia with surgical resolution</dc:title>
<dc:description xml:lang="en">Unilateral adrenal hyperplasia is a rare cause of primary hyperaldosteronism (around a 3%) that has surgical treatment. A case of a patient with hypertension resistant to conventional therapy in treatment with 7 drugs who presented with primary hyperaldosteronism due to unilateral adrenal hyperplasia is presented. A left adrenalectomy was performed, and the patient had a good clinical response, with no need of any drug after 2 years of surgery. Unilateral adrenal hyperplasia is a different entity and it is not an asymmetric variant of the bilateral adrenal hyperplasia. In the study of patients with primary hyperaldosteronism and imaging tests with absence of adenoma is a diagnosis that must be considered before cataloguing patients with bilateral adrenal hyperplasia and start a medical treatment, because unilateral adrenal hyperplasia would have a surgical resolution (AU)</dc:description>
<dc:creator>Salom Vendrell, C</dc:creator>
<dc:creator>Rubio Puchol, O</dc:creator>
<dc:creator>Garzón Pastor, S</dc:creator>
<dc:creator>Hernández-Mijares,  A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La hiperplasia suprarrenal unilateral es una causa rara de hiperaldosteronismo primario (sobre un 3%) que tiene tratamiento quirúrgico. Presentamos el caso de una mujer de 50 años con hipertensión arterial refractaria en tratamiento con 7 fármacos con hiperaldosteronismo primario por hiperplasia suprarrenal unilateral, que tras suprarrenalectomía izquierda presenta curación sin necesidad de ningún fármaco antihipertensivo tras 2 años desde la cirugía. La hiperplasia suprarrenal unilateral es una entidad diferente y no es una variante asimétrica de la hiperplasia bilateral. En el estudio de pacientes con hiperaldosteronismo primario y pruebas de imagen sin presencia de adenoma suprarrenal, es un diagnóstico que hay que considerar antes de catalogar a los pacientes con hiperplasia suprarrenal bilateral y de iniciar tratamiento médico, ya que la hiperplasia unilateral tendría resolución quirúrgica (AU)</dc:description>
<dc:source>Hipertens. riesgo vasc;33(4): 155-158, oct.-dic. 2016. ilus</dc:source>
<dc:identifier>ibc-157557</dc:identifier>
<dc:title xml:lang="es">Hiperaldosteronismo primario por hiperplasia suprarrenal unilateral con resolución quirúrgica</dc:title>
<dc:subject>^d310^s22012</dc:subject>
<dc:subject>^d13531^s22073</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7152^s22012</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d7117^s22057</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d55918^s22073</dc:subject>
<dc:subject>^d7108^s22027</dc:subject>
<dc:subject>^d22164</dc:subject>
<dc:type>article</dc:type>
<dc:date>201612</dc:date>
</metadata>
</record>
</ibecs-document>
